Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Moshe Sade-Feldman, Ph.D.

Concepts (212)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Moshe Sade-Feldman's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Moshe Sade-Feldman has written about over time.
Inflammation, 7 publications between 2012 and 2015, average publication date December 2013. Myeloid Cells, 8 publications between 2012 and 2021, average publication date January 2015. HLA-DR Antigens, 1 publications between 2016 and 2016, average publication date May 2016. Antigen Presentation, 1 publications between 2017 and 2017, average publication date October 2017. Tumor Microenvironment, 11 publications between 2012 and 2024, average publication date July 2019. Immunotherapy, 7 publications between 2012 and 2024, average publication date November 2019. Melanoma, 13 publications between 2012 and 2024, average publication date December 2019. Drug Resistance, Neoplasm, 3 publications between 2017 and 2023, average publication date February 2020. CD8-Positive T-Lymphocytes, 4 publications between 2018 and 2024, average publication date January 2021. Single-Cell Analysis, 5 publications between 2020 and 2024, average publication date August 2021. Sepsis, 2 publications between 2021 and 2023, average publication date April 2022. Sequence Analysis, RNA, 5 publications between 2019 and 2024, average publication date August 2022. Neutrophils, 3 publications between 2022 and 2023, average publication date December 2022.

To see the data from this visualization as text, click here.
Sade-Feldman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (212)
Explore
_
Co-Authors (143)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.